Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bio-Rad Adds New PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, October 22, 2014
This release expands Bio-Rad’s current offering of predesigned and fully wet-lab validated assays.

Bio-Rad Introduces Real-Time PCR Assays for Rat Genome
Thursday, October 09, 2014
Wet-lab validated PrimePCR™ Rat Genome Assays ensure accurate quantitative PCR results.

Mobidiag Announces CE-IVD Marking of Amplidiag™ Bacterial GE
Thursday, September 25, 2014
Test optimizes screening of gastroenteritis-causing bacteria directly from stool samples.

Tecan Offers NGS Sample Preparation at the Touch of a Button
Friday, September 19, 2014
Tecan’s Freedom EVO NGS workstation to offer robust and reliable automation.

Agilent Introduces Modular Real-Time PCR System
Friday, September 12, 2014
Instrument Provides High Resolution, Less Interference Between Channels.

Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™
Friday, September 12, 2014
Idylla™’s first test identifies cancers driven by the BRAF oncogene. Cancer patients will benefit significantly from faster therapy decisions and better guidance of treatment choices.

New Eppendorf Advantage™ Offers
Tuesday, September 02, 2014
Users start their research with great sample prep from Eppendorf.

PrimerDesign Launches World’s Most Affordable qPCR Instrument
Wednesday, August 20, 2014
With a price tag of £3,995 GBP ($6,500 USD) and an ultra-simplified user experience, the instrument, in combination with a new easy-to-use genesig kit range, is designed to make the power of qPCR accessible to a vast swathe of new users.

Improve Gene Expression Results with Bio-Rad’s New Rapid Cell Lysis RT-qPCR Kits
Monday, August 18, 2014
The kits allow researchers to obtain reverse transcription quantitative PCR (RT-qPCR) data directly from cultured cells without the need for a separate RNA purification step.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 587
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv